This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clarridge, J. E.
Right arrow Articles by Waddington, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clarridge, J. E., III
Right arrow Articles by Waddington, M.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, November 1999, p. 3681-3687, Vol. 37, No. 11
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Genotypic and Phenotypic Characterization of "Streptococcus milleri" Group Isolates from a Veterans Administration Hospital Population

Jill E. Clarridge III,1,2,3,* Cheryl Osting,3 Mehri Jalali,1 Janet Osborne,3 and Michael Waddington4

Department of Pathology1 and Department of Microbiology and Immunology,2 Baylor College of Medicine, and Pathology and Laboratory Medicine Service, Veterans Affairs Medical Center,3 Houston, Texas, and MIDI Labs Inc., Newark, Delaware4

Received 25 May 1999/Returned for modification 8 July 1999/Accepted 9 August 1999

Because identification of the species within the "Streptococcus milleri" group is difficult for the clinical laboratory as the species share overlapping phenotypic characteristics, we wished to confirm biochemical identification with identification by 16S rRNA gene sequence analysis. Ninety-four clinical isolates previously identified as the "Streptococcus milleri" group were reclassified as S. anginosus, S. constellatus, or S. intermedius with the API 20 Strep system (bioMerieux Vikek, Hazelton, Mo.) and the Fluo-card (Key Scientific, Round Rock, Tex.). In addition, we determined the Lancefield group, hemolysis, colony size, colony texture, repetitive extragenic palindromic PCR (rep-PCR) pattern, and cellular fatty acid (CFA) profile (MIDI, Newark, Del.). 16S rRNA gene sequence analysis with 40 selected representative strains showed three distinct groups, with S. constellatus and S. intermedius found to be more closely related to each other than to S. anginosus, and further distinguished a biochemically distinct group of urogenital isolates within the S. anginosus group of isolates. Except for strains unreactive with the Fluo-card (8%), all S. anginosus and S. intermedius strains identified by sequencing were similarly identified by biochemical testing. However, 23% of the selected S. constellatus isolates identified by sequencing (9% of all S. constellatus isolates) would have been identified as S. anginosus or S. intermedius by biochemical tests. Although most S. anginosus strains formed one unique cluster by CFA analysis and most S. constellatus strains showed similar rep-PCR patterns, neither method was sufficiently dependable for identification. Whereas Lancefield group or lactose fermentation did not correspond to sequence or biochemical type, S. constellatus was most likely to be beta-hemolytic and S. intermedius was most likely to have a dry colony type. The most frequent isolate in our population was S. constellatus, followed by S. anginosus. There was an association of S. anginosus with a gastrointestinal or urogenital source, and there was an association of S. constellatus and S. intermedius with both the respiratory tract and upper-body abscesses.


* Corresponding author. Mailing address: Pathology and Laboratory Medicine Services (113), VA Medical Center and Baylor College of Medicine, 2002 Holcombe Blvd., Houston, TX 77030. Phone: (713) 794-7336. Fax: (713) 794-7657. E-mail: jillc{at}bcm.tmc.edu.


Journal of Clinical Microbiology, November 1999, p. 3681-3687, Vol. 37, No. 11
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Asmah, N., Eberspacher, B., Regnath, T., Arvand, M. (2009). Prevalence of erythromycin and clindamycin resistance among clinical isolates of the Streptococcus anginosus group in Germany. J Med Microbiol 58: 222-227 [Abstract] [Full Text]  
  • Sibley, C. D., Parkins, M. D., Rabin, H. R., Duan, K., Norgaard, J. C., Surette, M. G. (2008). A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients. Proc. Natl. Acad. Sci. USA 105: 15070-15075 [Abstract] [Full Text]  
  • Daley, P., Church, D. L., Gregson, D. B., Elsayed, S. (2005). Species-Level Molecular Identification of Invasive "Streptococcus milleri" Group Clinical Isolates by Nucleic Acid Sequencing in a Centralized Regional Microbiology Laboratory. J. Clin. Microbiol. 43: 2987-2988 [Abstract] [Full Text]  
  • Clarridge, J. E. III (2004). Impact of 16S rRNA Gene Sequence Analysis for Identification of Bacteria on Clinical Microbiology and Infectious Diseases. Clin. Microbiol. Rev. 17: 840-862 [Abstract] [Full Text]  
  • Mundia, M., Edelstein, P. H., Friedlander, R. M., Slotkin, J. R. (2003). Case 16-2003 -- Brain Abscess. NEJM 349: 1004-1006 [Full Text]  
  • Tracy, M., Wanahita, A., Shuhatovich, Y., Goldsmith, E. A., Clarridge, J. E. III, Musher, D. M. (2001). Antibiotic Susceptibilities of Genetically Characterized Streptococcus milleri Group Strains. Antimicrob. Agents Chemother. 45: 1511-1514 [Abstract] [Full Text]  
  • Clarridge, J. E. III, Attorri, S. M., Zhang, Q., Bartell, J. (2001). 16S Ribosomal DNA Sequence Analysis Distinguishes Biotypes of Streptococcus bovis: Streptococcus bovis Biotype II/2 Is a Separate Genospecies and the Predominant Clinical Isolate in Adult Males. J. Clin. Microbiol. 39: 1549-1552 [Abstract] [Full Text]